NuSmile, Ltd. appears in FDA device records as the applicant for NeoPEX™ Pre-Mixed Obturation Paste, cleared under K253909 with a substantially equivalent decision dated September 4, 2026. The filing identifies the device as a Class II root canal filling resin regulated under 21 CFR 872.3820, with product codes KIF and EJK, reviewed by the Dental advisory committee. The submission was received December 8, 2025, and the clearance letter is dated the same September 2026 decision date. NuSmile’s own published site lists a Houston, Texas address and customer contact numbers, and describes the company in pediatric dental terms through its product lines. [1][2][3]

The NeoPEX filing and its regulatory scope

K253909 covers NeoPEX™ Pre-Mixed Obturation Paste as a traditional 510(k) with a Summary statement and no third-party review. The FDA record lists the applicant as NuSmile, Ltd. at 3315 W. 12th St., Houston, Texas 77008, with Priscilla Lara as contact. The clearance letter names the trade device, regulation number 21 CFR 872.3820, regulatory class II, and product codes KIF and EJK. The decision description is Substantially Equivalent, and the review advisory committee is Dental. [1][2]

The clearance letter includes a comparison table stating the device conforms to applicable parts of ISO 6876, releases calcium ions, and reaches a pH above 11 when hydrated, described as a high pH environment due to calcium hydroxide release. These are filing-level statements about the device’s documented characteristics, not clinical outcome data. [2]

Company identity and published contact details

NuSmile’s published website lists 3315 W 12th Street, Houston, TX 77008, with phone numbers 713.861.0033 and 1.800.346.5133, and links to company information, team, quality policy, and privacy pages. The site also references NuSmile Pediatric Crowns in its location link and a BioFlx territory map under customer support. These details are attributed to the manufacturer’s published site. [3]

A separate NuSmile testing-environment page repeats the same Houston address and phone numbers and carries a notice that orders placed there will not be processed. That page is a development environment, so its product and ordering content cannot be read as commercial availability. [5]

Third-party listings and collection context

A third-party device database lists NeoPEX™ Pre-Mixed Obturation Paste as a Class II device cleared under K253909 on September 4, 2026, active as of October 25, 2026, with no expiry and no FDA recalls found in data synced that date. The same listing shows other NuSmile devices, including NuCem entries, and marks its own trust status as unverified. [4]

Another third-party guide describes NuSmile, Ltd. as a Houston, Texas manufacturer registered with FDA, listing 18 dental device types, 91 brands and models, two 510(k) clearances from 2019 to 2026, one U.S. establishment, and registration in 15 markets with 162 registrations outside the U.S., with FDA data as of November 2, 2026. Those figures are that publisher’s counts, not totals confirmed by FDA records here. [6]

In the linked filing collection, one 510(k) record is present, with a decision count of one Substantially Equivalent and a record sample of the same single entry. That is a snapshot of the linked records, not a measure of total portfolio, sales, or safety performance. [1]